Publications 2024

Majid U, Bergsland CH, Sveen A, Bruun J, Eilertsen IA, Bækkevold ES, Nesbakken A, Yaqub S, Jahnsen FL, Lothe RA (2024)
The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration
Cell Oncol (Dordr) (in press)
DOI 10.1007/s13402-024-00926-w, PubMed 38407700

Publications 2023

Rostoft S, Thomas MJ, Slaaen M, Møller B, Nesbakken A, Syse A (2023)
Hospital use and cancer treatment by age and socioeconomic status in the last year of life: A Norwegian population-based study of patients dying of cancer
J Geriatr Oncol, 15 (2), 101683
DOI 10.1016/j.jgo.2023.101683, PubMed 38065011

Publications 2022

Bergsland CH, Jeanmougin M, Moosavi SH, Svindland A, Bruun J, Nesbakken A, Sveen A, Lothe RA (2022)
Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer
Mod Pathol, 35 (9), 1236-1246
DOI 10.1038/s41379-022-01086-8, PubMed 35484226

Kleppe A, Skrede OJ, De Raedt S, Hveem TS, Askautrud HA, Jacobsen JE, Church DN, Nesbakken A, Shepherd NA, Novelli M, Kerr R, Liestøl K, Kerr DJ, Danielsen HE (2022)
A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study
Lancet Oncol, 23 (9), 1221-1232
DOI 10.1016/S1470-2045(22)00391-6, PubMed 35964620

Publications 2021

Berg KCG, Brunsell TH, Sveen A, Alagaratnam S, Bjørnslett M, Hektoen M, Brudvik KW, Røsok BI, Bjørnbeth BA, Nesbakken A, Lothe RA (2021)
Genomic and prognostic heterogeneity among RAS/BRAF^V600E /TP53 co-mutated resectable colorectal liver metastases
Mol Oncol, 15 (4), 830-845
DOI 10.1002/1878-0261.12885, PubMed 33325154

Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T (2021)
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Mol Oncol, 16 (12), 2312-2329
DOI 10.1002/1878-0261.13159, PubMed 34890102

Eide PW, Moosavi SH, Eilertsen IA, Brunsell TH, Langerud J, Berg KCG, Røsok BI, Bjørnbeth BA, Nesbakken A, Lothe RA, Sveen A (2021)
Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
NPJ Genom Med, 6 (1), 59
DOI 10.1038/s41525-021-00223-7, PubMed 34262039

Kleive D, Aas E, Angelsen JH, Bringeland EA, Nesbakken A, Nymo LS, Schultz JK, Søreide K, Yaqub S (2021)
Simultaneous Resection of Primary Colorectal Cancer and Synchronous Liver Metastases: Contemporary Practice, Evidence and Knowledge Gaps
Oncol Ther, 9 (1), 111-120
DOI 10.1007/s40487-021-00148-2, PubMed 33759076

Kryeziu K, Moosavi SH, Bergsland CH, Guren MG, Eide PW, Totland MZ, Lassen K, Abildgaard A, Nesbakken A, Sveen A, Lothe RA (2021)
Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
J Transl Med, 19 (1), 384
DOI 10.1186/s12967-021-03062-3, PubMed 34496878

Moosavi SH, Eide PW, Eilertsen IA, Brunsell TH, Berg KCG, Røsok BI, Brudvik KW, Bjørnbeth BA, Guren MG, Nesbakken A, Lothe RA, Sveen A (2021)
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
Genome Med, 13 (1), 143
DOI 10.1186/s13073-021-00956-1, PubMed 34470666

Slørdahl KS, Klotz D, Olsen JÅ, Skovlund E, Undseth C, Abildgaard HL, Brændengen M, Nesbakken A, Larsen SG, Hanekamp BA, Holmboe L, Tvedt R, Sveen A, Lothe RA, Malinen E, Kaasa S, Guren MG (2021)
Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer
Acta Oncol, 60 (7), 921-930
DOI 10.1080/0284186X.2021.1918763, PubMed 33966592

Sveen A, Johannessen B, Eilertsen IA, Røsok BI, Gulla M, Eide PW, Bruun J, Kryeziu K, Meza-Zepeda LA, Myklebost O, Bjørnbeth BA, Skotheim RI, Nesbakken A, Lothe RA (2021)
The expressed mutational landscape of microsatellite stable colorectal cancers
Genome Med, 13 (1), 142
DOI 10.1186/s13073-021-00955-2, PubMed 34470667

Publications 2020

Bergsland CH, Bruun J, Guren MG, Svindland A, Bjørnslett M, Smeby J, Hektoen M, Kolberg M, Domingo E, Pellinen T, Tomlinson I, Kerr D, Church DN, Nesbakken A, Sveen A, Lothe RA (2020)
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
ESMO Open, 5 (6), e001040
DOI 10.1136/esmoopen-2020-001040, PubMed 33219056

Bruun J, Kryeziu K, Eide PW, Moosavi SH, Eilertsen IA, Langerud J, Røsok B, Totland MZ, Brunsell TH, Pellinen T, Saarela J, Bergsland CH, Palmer HG, Brudvik KW, Guren T, Dienstmann R, Guren MG, Nesbakken A, Bjørnbeth BA, Sveen A, Lothe RA (2020)
Patient-Derived Organoids from Multiple Colorectal Cancer Liver Metastases Reveal Moderate Intra-patient Pharmacotranscriptomic Heterogeneity
Clin Cancer Res, 26 (15), 4107-4119
DOI 10.1158/1078-0432.CCR-19-3637, PubMed 32299813

Skrede OJ, De Raedt S, Kleppe A, Hveem TS, Liestøl K, Maddison J, Askautrud HA, Pradhan M, Nesheim JA, Albregtsen F, Farstad IN, Domingo E, Church DN, Nesbakken A, Shepherd NA, Tomlinson I, Kerr R, Novelli M, Kerr DJ, Danielsen HE (2020)
Deep learning for prediction of colorectal cancer outcome: a discovery and validation study
Lancet, 395 (10221), 350-360
DOI 10.1016/S0140-6736(19)32998-8, PubMed 32007170

Smeby J, Kryeziu K, Berg KCG, Eilertsen IA, Eide PW, Johannessen B, Guren MG, Nesbakken A, Bruun J, Lothe RA, Sveen A (2020)
Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
EBioMedicine, 59, 102923
DOI 10.1016/j.ebiom.2020.102923, PubMed 32799124

Publications 2019

Berg KCG, Sveen A, Høland M, Alagaratnam S, Berg M, Danielsen SA, Nesbakken A, Søreide K, Lothe RA (2019)
Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains
Oncogene, 38 (33), 6109-6122
DOI 10.1038/s41388-019-0868-5, PubMed 31308487

Brunsell TH, Cengija V, Sveen A, Bjørnbeth BA, Røsok BI, Brudvik KW, Guren MG, Lothe RA, Abildgaard A, Nesbakken A (2019)
Heterogeneous radiological response to neoadjuvant therapy is associated with poor prognosis after resection of colorectal liver metastases
Eur J Surg Oncol, 45 (12), 2340-2346
DOI 10.1016/j.ejso.2019.07.017, PubMed 31350075

Brunsell TH, Sveen A, Bjørnbeth BA, Røsok BI, Danielsen SA, Brudvik KW, Berg KCG, Johannessen B, Cengija V, Abildgaard A, Guren MG, Nesbakken A, Lothe RA (2019)
High Concordance and Negative Prognostic Impact of RAS/BRAF/PIK3CA Mutations in Multiple Resected Colorectal Liver Metastases
Clin Colorectal Cancer, 19 (1), e26-e47
DOI 10.1016/j.clcc.2019.09.003, PubMed 31982351

Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, Moreno V, Warren RS, Lothe RA, Guinney J (2019)
Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
Ann Oncol, 30 (10), 1622-1629
DOI 10.1093/annonc/mdz287, PubMed 31504112

Eilertsen IA, Moosavi SH, Strømme JM, Nesbakken A, Johannessen B, Lothe RA, Sveen A (2019)
Technical differences between sequencing and microarray platforms impact transcriptomic subtyping of colorectal cancer
Cancer Lett, 469, 246-255
DOI 10.1016/j.canlet.2019.10.040, PubMed 31678167

Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
Tumour-infiltrating CD8⁺ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Br J Cancer, 121 (6), 474-482
DOI 10.1038/s41416-019-0540-4, PubMed 31388185

Glaire MA, Domingo E, Sveen A, Bruun J, Nesbakken A, Nicholson G, Novelli M, Lawson K, Oukrif D, Kildal W, Danielsen HE, Kerr R, Kerr D, Tomlinson I, Lothe RA, Church DN (2019)
Correction: Tumour-infiltrating CD8⁺ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
Br J Cancer, 121 (9), 807
DOI 10.1038/s41416-019-0590-7, PubMed 31548598

Joranger P, Nesbakken A, Sorbye H, Hoff G, Oshaug A, Aas E (2019)
Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach
Eur J Health Econ, 21 (3), 321-334
DOI 10.1007/s10198-019-01130-6, PubMed 31707584

Lopes N, Bergsland CH, Bjørnslett M, Pellinen T, Svindland A, Nesbakken A, Almeida R, Lothe RA, David L, Bruun J (2019)
Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2
Lab Invest, 100 (1), 120-134
DOI 10.1038/s41374-019-0336-4, PubMed 31641225

Smeby J, Sveen A, Bergsland CH, Eilertsen IA, Danielsen SA, Eide PW, Hektoen M, Guren MG, Nesbakken A, Bruun J, Lothe RA (2019)
Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
ESMO Open, 4 (3), e000523
DOI 10.1136/esmoopen-2019-000523, PubMed 31321083

Smeby J, Sveen A, Eilertsen IA, Danielsen SA, Hoff AM, Eide PW, Johannessen B, Hektoen M, Skotheim RI, Guren MG, Nesbakken A, Lothe RA (2019)
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer
Oncogenesis, 8 (6), 35
DOI 10.1038/s41389-019-0141-3, PubMed 31092812

Publications 2018

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA (2018)
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
Mol Oncol, 12 (9), 1639-1655
DOI 10.1002/1878-0261.12347, PubMed 29900672

Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ (2018)
Prognostic markers for colorectal cancer: estimating ploidy and stroma
Ann Oncol, 29 (3), 616-623
DOI 10.1093/annonc/mdx794, PubMed 29293881

Eilertsen IA, Sveen A, Strømme JM, Skotheim RI, Nesbakken A, Lothe RA (2018)
Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
Int J Cancer, 144 (4), 841-847
DOI 10.1002/ijc.31809, PubMed 30121958

Gleditsch D, Wexels WA, Nesbakken A (2018)
Surgical options and trends in treating rectal prolapse: long-term results in a 19-year follow-up study
Langenbecks Arch Surg, 403 (8), 991-998
DOI 10.1007/s00423-018-1728-4, PubMed 30415286

Kleppe A, Albregtsen F, Vlatkovic L, Pradhan M, Nielsen B, Hveem TS, Askautrud HA, Kristensen GB, Nesbakken A, Trovik J, Wæhre H, Tomlinson I, Shepherd NA, Novelli M, Kerr DJ, Danielsen HE (2018)
Chromatin organisation and cancer prognosis: a pan-cancer study
Lancet Oncol, 19 (3), 356-369
DOI 10.1016/S1470-2045(17)30899-9, PubMed 29402700

Ommundsen N, Nesbakken A, Wyller TB, Skovlund E, Bakka AO, Jordhøy MS, Rostoft S (2018)
Post-discharge complications in frail older patients after surgery for colorectal cancer
Eur J Surg Oncol, 44 (10), 1542-1547
DOI 10.1016/j.ejso.2018.06.024, PubMed 30037638

Ommundsen N, Wyller TB, Nesbakken A, Bakka AO, Jordhøy MS, Skovlund E, Rostoft S (2018)
Preoperative geriatric assessment and tailored interventions in frail older patients with colorectal cancer: a randomized controlled trial
Colorectal Dis, 20 (1), 16-25
DOI 10.1111/codi.13785, PubMed 28649755

Ommundsen N, Wyller TB, Nesbakken A, Bakka AO, Jordhøy MS, Skovlund E, Rostoft S (2018)
Reply to Lawday et al
Colorectal Dis, 20 (4), 350-351
DOI 10.1111/codi.14059, PubMed 29502337

Smeby J, Sveen A, Merok MA, Danielsen SA, Eilertsen IA, Guren MG, Dienstmann R, Nesbakken A, Lothe RA (2018)
CMS-dependent prognostic impact of KRAS and BRAFV600E mutations in primary colorectal cancer
Ann Oncol, 29 (5), 1227-1234
DOI 10.1093/annonc/mdy085, PubMed 29518181

Vedeld HM, Nesbakken A, Lothe RA, Lind GE (2018)
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
Clin Epigenetics, 10, 70
DOI 10.1186/s13148-018-0503-2, PubMed 29854011

Publications 2017

Dienstmann R, Mason MJ, Sinicrope FA, Phipps AI, Tejpar S, Nesbakken A, Danielsen SA, Sveen A, Buchanan DD, Clendenning M, Rosty C, Bot B, Alberts SR, Milburn Jessup J, Lothe RA, Delorenzi M, Newcomb PA, Sargent D, Guinney J (2017)
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
Ann Oncol, 28 (5), 1023-1031
DOI 10.1093/annonc/mdx052, PubMed 28453697

Labori KJ, Guren MG, Brudvik KW, Røsok BI, Waage A, Nesbakken A, Larsen S, Dueland S, Edwin B, Bjørnbeth BA (2017)
Resection of synchronous liver metastases between radiotherapy and definitive surgery for locally advanced rectal cancer: short-term surgical outcomes, overall survival and recurrence-free survival
Colorectal Dis, 19 (8), 731-738
DOI 10.1111/codi.13622, PubMed 28181384

Sveen A, Bruun J, Eide PW, Eilertsen IA, Ramirez L, Murumägi A, Arjama M, Danielsen SA, Kryeziu K, Elez E, Tabernero J, Guinney J, Palmer HG, Nesbakken A, Kallioniemi O, Dienstmann R, Lothe RA (2017)
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies
Clin Cancer Res, 24 (4), 794-806
DOI 10.1158/1078-0432.CCR-17-1234, PubMed 29242316

Sveen A, Johannessen B, Tengs T, Danielsen SA, Eilertsen IA, Lind GE, Berg KCG, Leithe E, Meza-Zepeda LA, Domingo E, Myklebost O, Kerr D, Tomlinson I, Nesbakken A, Skotheim RI, Lothe RA (2017)
Multilevel genomics of colorectal cancers with microsatellite instability-clinical impact of JAK1 mutations and consensus molecular subtype 1
Genome Med, 9 (1), 46
DOI 10.1186/s13073-017-0434-0, PubMed 28539123

Vedeld HM, Merok M, Jeanmougin M, Danielsen SA, Honne H, Presthus GK, Svindland A, Sjo OH, Hektoen M, Eknaes M, Nesbakken A, Lothe RA, Lind GE (2017)
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
Int J Cancer, 141 (5), 967-976
DOI 10.1002/ijc.30796, PubMed 28542846

Publications 2016

Boye K, Jacob H, Frikstad KA, Nesland JM, Maelandsmo GM, Dahl O, Nesbakken A, Flatmark K (2016)
Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy
Cancer Med, 5 (8), 1840-9
DOI 10.1002/cam4.766, PubMed 27273130

Domingo E, Freeman-Mills L, Rayner E, Glaire M, Briggs S, Vermeulen L, Fessler E, Medema JP, Boot A, Morreau H, van Wezel T, Liefers GJ, Lothe RA, Danielsen SA, Sveen A, Nesbakken A, Zlobec I, Lugli A, Koelzer VH, Berger MD, Castellví-Bel S, Muñoz J, Epicolon consortium, de Bruyn M, Nijman HW et al. (2016)
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Lancet Gastroenterol Hepatol, 1 (3), 207-216
DOI 10.1016/S2468-1253(16)30014-0, PubMed 28404093

Gleditsch D, Søreide OK, Nesbakken A (2016)
Managing Malignant Colorectal Obstruction with Self-Expanding Stents. A Closer Look at Bowel Perforations and Failed Procedures
J Gastrointest Surg, 20 (9), 1643-9
DOI 10.1007/s11605-016-3186-z, PubMed 27342437

Rønning B, Wyller TB, Nesbakken A, Skovlund E, Jordhøy MS, Bakka A, Rostoft S (2016)
Quality of life in older and frail patients after surgery for colorectal cancer-A follow-up study
J Geriatr Oncol, 7 (3), 195-200
DOI 10.1016/j.jgo.2016.03.002, PubMed 27067579

Stornes T, Wibe A, Nesbakken A, Myklebust TÅ, Endreseth BH (2016)
National Early Rectal Cancer Treatment Revisited
Dis Colon Rectum, 59 (7), 623-9
DOI 10.1097/DCR.0000000000000591, PubMed 27270514

Publications 2015

Bruun J, Kolberg M, Ahlquist TC, Røyrvik EC, Nome T, Leithe E, Lind GE, Merok MA, Rognum TO, Bjørkøy G, Johansen T, Lindblom A, Sun XF, Svindland A, Liestøl K, Nesbakken A, Skotheim RI, Lothe RA (2015)
Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer
Clin Cancer Res, 21 (16), 3759-70
DOI 10.1158/1078-0432.CCR-14-3294, PubMed 25910952

Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A (2015)
Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010
Acta Oncol, 54 (10), 1714-22
DOI 10.3109/0284186X.2015.1034876, PubMed 25924970

Publications 2014

Bruun J, Kolberg M, Nesland JM, Svindland A, Nesbakken A, Lothe RA (2014)
Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series
Front Oncol, 4, 118
DOI 10.3389/fonc.2014.00118, PubMed 24904831

Danielsen SA, Eide PW, Nesbakken A, Guren T, Leithe E, Lothe RA (2014)
Portrait of the PI3K/AKT pathway in colorectal cancer
Biochim Biophys Acta, 1855 (1), 104-21
DOI 10.1016/j.bbcan.2014.09.008, PubMed 25450577

Hveem TS, Merok MA, Pretorius ME, Novelli M, Bævre MS, Sjo OH, Clinch N, Liestøl K, Svindland A, Lothe RA, Nesbakken A, Danielsen HE (2014)
Prognostic impact of genomic instability in colorectal cancer
Br J Cancer, 110 (8), 2159-64
DOI 10.1038/bjc.2014.133, PubMed 24642618

Ingebrigtsen VA, Boye K, Nesland JM, Nesbakken A, Flatmark K, Fodstad Ø (2014)
B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome
BMC Cancer, 14, 602
DOI 10.1186/1471-2407-14-602, PubMed 25139714

Joranger P, Nesbakken A, Hoff G, Sorbye H, Oshaug A, Aas E (2014)
Modeling and validating the cost and clinical pathway of colorectal cancer
Med Decis Making, 35 (2), 255-65
DOI 10.1177/0272989X14544749, PubMed 25073464

Løvf M, Nome T, Bruun J, Eknaes M, Bakken AC, Mpindi JP, Kilpinen S, Rognum TO, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI (2014)
A novel transcript, VNN1-AB, as a biomarker for colorectal cancer
Int J Cancer, 135 (9), 2077-84
DOI 10.1002/ijc.28855, PubMed 24687856

Nome T, Hoff AM, Bakken AC, Rognum TO, Nesbakken A, Skotheim RI (2014)
High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants
PLoS One, 9 (3), e91264
DOI 10.1371/journal.pone.0091264, PubMed 24608966

Ommundsen N, Wyller TB, Nesbakken A, Jordhøy MS, Bakka A, Skovlund E, Rostoft S (2014)
Frailty is an independent predictor of survival in older patients with colorectal cancer
Oncologist, 19 (12), 1268-75
DOI 10.1634/theoncologist.2014-0237, PubMed 25355846

Søndenaa K, Quirke P, Hohenberger W, Sugihara K, Kobayashi H, Kessler H, Brown G, Tudyka V, D'Hoore A, Kennedy RH, West NP, Kim SH, Heald R, Storli KE, Nesbakken A, Moran B (2014)
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference
Int J Colorectal Dis, 29 (4), 419-28
DOI 10.1007/s00384-013-1818-2, PubMed 24477788

Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM, Lind GE (2014)
The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers
Int J Cancer, 136 (4), 844-53
DOI 10.1002/ijc.29039, PubMed 24948044

Publications 2013

Nedrebø BS, Søreide K, Nesbakken A, Eriksen MT, Søreide JA, Kørner H, Norwegian Colorectal Cancer Group (2013)
Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort
Colorectal Dis, 15 (6), e301-8
DOI 10.1111/codi.12245, PubMed 23582027

Nome T, Thomassen GO, Bruun J, Ahlquist T, Bakken AC, Hoff AM, Rognum T, Nesbakken A, Lorenz S, Sun J, Barros-Silva JD, Lind GE, Myklebost O, Teixeira MR, Meza-Zepeda LA, Lothe RA, Skotheim RI (2013)
Common fusion transcripts identified in colorectal cancer cell lines by high-throughput RNA sequencing
Transl Oncol, 6 (5), 546-53
DOI 10.1593/tlo.13457, PubMed 24151535

Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
Frailty indicators and functional status in older patients after colorectal cancer surgery
J Geriatr Oncol, 5 (1), 26-32
DOI 10.1016/j.jgo.2013.08.001, PubMed 24484715

Sveen A, Nesbakken A, Ågesen TH, Guren MG, Tveit KM, Skotheim RI, Lothe RA (2013)
Anticipating the clinical use of prognostic gene expression-based tests for colon cancer stage II and III: is Godot finally arriving?
Clin Cancer Res, 19 (24), 6669-77
DOI 10.1158/1078-0432.CCR-13-1769, PubMed 24166914

Publications 2012

Agesen TH, Sveen A, Merok MA, Lind GE, Nesbakken A, Skotheim RI, Lothe RA (2012)
ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis
Gut, 61 (11), 1560-7
DOI 10.1136/gutjnl-2011-301179, PubMed 22213796

Ahmed D, Danielsen SA, Aagesen TH, Bretthauer M, Thiis-Evensen E, Hoff G, Rognum TO, Nesbakken A, Lothe RA, Lind GE (2012)
A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors
Clin Transl Gastroenterol, 3 (12), e27
DOI 10.1038/ctg.2012.21, PubMed 23324654

Cekaite L, Rantala JK, Bruun J, Guriby M, Agesen TH, Danielsen SA, Lind GE, Nesbakken A, Kallioniemi O, Lothe RA, Skotheim RI (2012)
MiR-9, -31, and -182 deregulation promote proliferation and tumor cell survival in colon cancer
Neoplasia, 14 (9), 868-79
DOI 10.1593/neo.121094, PubMed 23019418

Kristjansson SR, Ronning B, Hurria A, Skovlund E, Jordhoy MS, Nesbakken A, Wyller TB (2012)
A comparison of two pre-operative frailty measures in older surgical cancer patients
J. Geriatr. Oncol., 3 (1), 1-7
DOI 10.1016/j.jgo.2011.09.002

Larssen L, Medhus AW, Körner H, Glomsaker T, Søberg T, Gleditsch D, Hovde Ø, Tholfsen JK, Skreden K, Nesbakken A, Hauge T (2012)
Long-term outcome of palliative treatment with self-expanding metal stents for malignant obstructions of the GI tract
Scand J Gastroenterol, 47 (12), 1505-14
DOI 10.3109/00365521.2012.711854, PubMed 23046494

Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, Sjo OH, Mala T, Svindland A, Lothe RA, Nesbakken A (2012)
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series
Ann Oncol, 24 (5), 1274-82
DOI 10.1093/annonc/mds614, PubMed 23235802

Sjo OH, Merok MA, Svindland A, Nesbakken A (2012)
Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer
Dis Colon Rectum, 55 (3), 307-15
DOI 10.1097/DCR.0b013e3182423f62, PubMed 22469798

Sveen A, Bakken AC, Ågesen TH, Lind GE, Nesbakken A, Nordgård O, Brackmann S, Rognum TO, Lothe RA, Skotheim RI (2012)
The exon-level biomarker SLC39A14 has organ-confined cancer-specificity in colorectal cancer
Int J Cancer, 131 (6), 1479-85
DOI 10.1002/ijc.27399, PubMed 22173985

Sveen A, Ågesen TH, Nesbakken A, Meling GI, Rognum TO, Liestøl K, Skotheim RI, Lothe RA (2012)
ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients
Clin Cancer Res, 18 (21), 6001-10
DOI 10.1158/1078-0432.CCR-11-3302, PubMed 22991413

Publications 2011

Andersson T, Lunde OC, Johnson E, Moum T, Nesbakken A (2011)
Long-term functional outcome and quality of life after restorative proctocolectomy with ileo-anal anastomosis for colitis
Colorectal Dis, 13 (4), 431-7
DOI 10.1111/j.1463-1318.2009.02163.x, PubMed 20002693

Danielsen SA, Cekaite L, Ågesen TH, Sveen A, Nesbakken A, Thiis-Evensen E, Skotheim RI, Lind GE, Lothe RA (2011)
Phospholipase C isozymes are deregulated in colorectal cancer--insights gained from gene set enrichment analysis of the transcriptome
PLoS One, 6 (9), e24419
DOI 10.1371/journal.pone.0024419, PubMed 21909432

Faerden AE, Sjo OH, Bukholm IR, Andersen SN, Svindland A, Nesbakken A, Bakka A (2011)
Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer
Dis Colon Rectum, 54 (2), 200-6
DOI 10.1007/DCR.0b013e3181fd4c7c, PubMed 21228669

Hølmebakk T, Solbakken A, Mala T, Nesbakken A (2011)
Clinical prediction of survival by surgeons for patients with incurable abdominal malignancy
Eur J Surg Oncol, 37 (7), 571-5
DOI 10.1016/j.ejso.2011.02.009, PubMed 21444178

Larssen L, Medhus AW, Hjermstad MJ, Körner H, Glomsaker T, Søberg T, Gleditsch D, Hovde O, Nesbakken A, Tholfsen JK, Skreden K, Hauge T (2011)
Patient-reported outcomes in palliative gastrointestinal stenting: a Norwegian multicenter study
Surg Endosc, 25 (10), 3162-9
DOI 10.1007/s00464-011-1680-7, PubMed 21487867

Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G, Bretthauer M, Thiis-Evensen E, Nesbakken A, Lothe RA (2011)
Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas
Mol Cancer, 10, 85
DOI 10.1186/1476-4598-10-85, PubMed 21777459

Lind GE, Raiborg C, Danielsen SA, Rognum TO, Thiis-Evensen E, Hoff G, Nesbakken A, Stenmark H, Lothe RA (2011)
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis
Oncogene, 30 (37), 3967-78
DOI 10.1038/onc.2011.109, PubMed 21499309

Nesbakken A, Kristinsson J, Svindland A, Lunde OC (2011)
Endoscopic snare resection followed by laser ablation in the treatment of large, sessile rectal adenomas
Scand J Surg, 100 (2), 99-104
DOI 10.1177/145749691110000206, PubMed 21737385

Sirnes S, Bruun J, Kolberg M, Kjenseth A, Lind GE, Svindland A, Brech A, Nesbakken A, Lothe RA, Leithe E, Rivedal E (2011)
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome
Int J Cancer, 131 (3), 570-81
DOI 10.1002/ijc.26392, PubMed 21866551

Sjo OH, Berg M, Merok MA, Kolberg M, Svindland A, Lothe RA, Nesbakken A (2011)
Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors
J Surg Oncol, 104 (7), 792-7
DOI 10.1002/jso.21959, PubMed 21547915

Sveen A, Agesen TH, Nesbakken A, Rognum TO, Lothe RA, Skotheim RI (2011)
Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival
Genome Med, 3 (5), 32
DOI 10.1186/gm248, PubMed 21619627

Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, Fetveit T, Vatn MH, Hovig E, Nesbakken A, Lothe RA, Skotheim RI (2011)
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
Genes Immun, 12 (8), 653-62
DOI 10.1038/gene.2011.43, PubMed 21716316

Publications 2010

Berg M, Agesen TH, Thiis-Evensen E, INFAC-study group, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, Skotheim RI, Lothe RA (2010)
Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci
Mol Cancer, 9, 100
DOI 10.1186/1476-4598-9-100, PubMed 20459617

Berg M, Danielsen SA, Ahlquist T, Merok MA, Ågesen TH, Vatn MH, Mala T, Sjo OH, Bakka A, Moberg I, Fetveit T, Mathisen Ø, Husby A, Sandvik O, Nesbakken A, Thiis-Evensen E, Lothe RA (2010)
DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset
PLoS One, 5 (11), e13978
DOI 10.1371/journal.pone.0013978, PubMed 21103049

Knævelsrud H, Ahlquist T, Merok MA, Nesbakken A, Stenmark H, Lothe RA, Simonsen A (2010)
UVRAG mutations associated with microsatellite unstable colon cancer do not affect autophagy
Autophagy, 6 (7), 863-70
DOI 10.4161/auto.6.7.13033, PubMed 20724836

Kristjansson SR, Jordhoy MS, Nesbakken A, Skovlund E, Bakka A, Johannessen HO, Wyller TB (2010)
Which elements of a comprehensive geriatric assessment (CGA) predict post-operative complications and early mortality after colorectal cancer surgery?
J. Geriatr. Oncol., 1 (2), 57-65
DOI 10.1016/j.jgo.2010.06.001

Nesbakken A (2010)
[Pilonidal disease--an underprioritized disorder]
Tidsskr Nor Laegeforen, 130 (9), 920
DOI 10.4045/tidsskr.10.0376, PubMed 20453940

Rønning B, Wyller TB, Seljeflot I, Jordhøy MS, Skovlund E, Nesbakken A, Kristjansson SR (2010)
Frailty measures, inflammatory biomarkers and post-operative complications in older surgical patients
Age Ageing, 39 (6), 758-61
DOI 10.1093/ageing/afq123, PubMed 20843962

Publications 2009

Baatrup G, Endreseth BH, Isaksen V, Kjellmo A, Tveit KM, Nesbakken A (2009)
Preoperative staging and treatment options in T1 rectal adenocarcinoma
Acta Oncol, 48 (3), 328-42
DOI 10.1080/02841860802657243, PubMed 19180365

Kristjansson SR, Nesbakken A, Jordhøy MS, Skovlund E, Audisio RA, Johannessen HO, Bakka A, Wyller TB (2009)
Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study
Crit Rev Oncol Hematol, 76 (3), 208-17
DOI 10.1016/j.critrevonc.2009.11.002, PubMed 20005123

Publications 2008

Faerden AE, Sjo OH, Andersen SN, Hauglann B, Nazir N, Gravdehaug B, Moberg I, Svinland A, Nesbakken A, Bakka A (2008)
Sentinel node mapping does not improve staging of lymph node metastasis in colonic cancer
Dis Colon Rectum, 51 (6), 891-6
DOI 10.1007/s10350-007-9185-0, PubMed 18259817

Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
[Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
Tidsskr Nor Laegeforen, 128 (21), 2440-2
PubMed 19096466

Mala T, Nesbakken A (2008)
Morbidity related to the use of a protective stoma in anterior resection for rectal cancer
Colorectal Dis, 10 (8), 785-8
DOI 10.1111/j.1463-1318.2007.01456.x, PubMed 18190612

Sjo OH, Larsen S, Lunde OC, Nesbakken A (2008)
Short term outcome after emergency and elective surgery for colon cancer
Colorectal Dis, 11 (7), 733-9
DOI 10.1111/j.1463-1318.2008.01613.x, PubMed 18624817

Søvik TT, Aasheim ET, Kristinsson J, Schou CF, Diep LM, Nesbakken A, Mala T (2008)
Establishing laparoscopic Roux-en-Y gastric bypass: perioperative outcome and characteristics of the learning curve
Obes Surg, 19 (2), 158-165
DOI 10.1007/s11695-008-9584-x, PubMed 18566869

Publications 2007

Hofstad B, Andersen SN, Nesbakken A (2007)
[Colorectal polyps]
Tidsskr Nor Laegeforen, 127 (20), 2692-5
PubMed 17952154

Nesbakken A, Gaard M (2007)
[Surgical treatment of colon cancer]
Tidsskr Nor Laegeforen, 127 (22), 2942-5
PubMed 18026241

Sjo OH, Lunde OC, Nygaard K, Sandvik L, Nesbakken A (2007)
Tumour location is a prognostic factor for survival in colonic cancer patients
Colorectal Dis, 10 (1), 33-40
DOI 10.1111/j.1463-1318.2007.01302.x, PubMed 17672872

Søvik TT, Aasheim ET, Kristinsson J, Schou CF, Nesbakken A, Mala T (2007)
[Surgical treatment of morbid obesity at a regional center]
Tidsskr Nor Laegeforen, 127 (1), 47-9
PubMed 17205090

Publications 2005

Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KM, Norwegian Rectal Cancer Group (2005)
Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer
Eur J Surg Oncol, 31 (7), 735-42
DOI 10.1016/j.ejso.2005.05.004, PubMed 16180267

Hølmebakk T, Nesbakken A (2005)
Surgery for pilonidal disease
Scand J Surg, 94 (1), 43-6
DOI 10.1177/145749690509400111, PubMed 15865116

Nesbakken A, Nygaard K, Lunde OC, Blücher J, Gjertsen Ø, Dullerud R (2005)
Anastomotic leak following mesorectal excision for rectal cancer: true incidence and diagnostic challenges
Colorectal Dis, 7 (6), 576-81
DOI 10.1111/j.1463-1318.2005.00870.x, PubMed 16232238

Publications 2003

Hølmebakk T, Nesbakken A (2003)
Operasjon for sinus pilonidalis sårinfeksjoner, tilhelingstid, residiv og kosmetisk resultat
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 72
BIBSYS 041733290

Hølmebakk T, Nesbakken A (2003)
Fra åpen til laparoskopisk appendektomi: gevinster og tap
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 92
BIBSYS 041733363

Nesbakken A (2003)
Mesorectal excision for rectal cancer: oncological outcome, long term functional outcome, intraoperative and postoperative complications
Department of Gastrointestinal Surgery, Aker University Hospital, Oslo, 1 b. (flere pag.)
BIBSYS 030457769, ISBN 82-8080-035-2

Nesbakken A, Løvig T, Lunde OC, Nygaard K (2003)
Staging of rectal carcinoma with transrectal ultrasonography
Scand J Surg, 92 (2), 125-9
DOI 10.1177/145749690309200203, PubMed 12841552

Nesbakken A, Løvig T, Lunde OC, Nygaard K (2003)
Staging of rectal carcinoma with transrectal ultrasonography
In Scandinavian journal of surgery: official organ for the Finnish Surgical Society and the Scandinavian Surgical Society, Vammalen Kirjapeino Oy, Helsinki, 92(2003)2, s.125-9
BIBSYS 041719492

Nesbakken A, Rosseland AR, Lunde OC (2003)
Stenting av malign colon-stenose
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 150
BIBSYS 041734351

Schou CF, Nesbakken A, Rosseland AR, Lunde OC (2003)
Stenting av gastroduodenal stenose
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 74
BIBSYS 041735528

Sjo OH, Nesbakken A, Lunde OC, Nygaard K, Mala T (2003)
Komplikasjoner etter operasjon for cancer coli
In Vitenskapelige forhandlinger, Norsk kirurgisk forening., [Oslo], 2003, Abstrakt 146
BIBSYS 041735544

Publications 2002

Nesbakken A, Nygaard K, Lunde OC (2002)
Mesorectal excision for rectal cancer: functional outcome after low anterior resection and colorectal anastomosis without a reservoir
Colorectal Dis, 4 (3), 172-176
DOI 10.1046/j.1463-1318.2002.00305.x, PubMed 12780611

Nesbakken A, Nygaard K, Lunde OC (2002)
Mesorectal excision for rectal cancer: functional outcome after low anterior resectionand colorectal anastomosis without a reservoir
In Colorectal disease, Blackwell, Oxford, 4(2002)nr 3, s. 172-176
BIBSYS 031283713

Nesbakken A, Nygaard K, Westerheim O, Lunde OC, Mala T (2002)
Audit of intraoperative and early postoperative complications after introduction of mesorectal excision for rectal cancer
Eur J Surg, 168 (4), 229-35
DOI 10.1080/11024150260102843, PubMed 12440761

Nesbakken A, Nygaard K, Westerheim O, Lunde OC, Mala T (2002)
Audit of intraoperative and early postoperative complications after introduction of mesorectal excision for rectal cancer
In European journal of surgery, Taylor & Francis, Basingstoke, 168(2002)nr 4, s. 229-235
BIBSYS 03128373x

Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC (2002)
Local recurrence after mesorectal excision for rectal cancer
Eur J Surg Oncol, 28 (2), 126-34
DOI 10.1053/ejso.2001.1231, PubMed 11884047

Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC (2002)
Local recurrence after mesorectal excision for rectal cancer
In European journal of surgical oncology, Academic Press, London, 25(2002)nr 2, s. 126-134
BIBSYS 031283675

Publications 2001

Gleditsch D, Nesbakken A, Nygaard K (2001)
[Sphincteroplasty in traumatic anal incontinence]
Tidsskr Nor Laegeforen, 121 (16), 1908-10
PubMed 11488181

Nesbakken A, Nygaard K, Lunde OC (2001)
Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer
Br J Surg, 88 (3), 400-4
DOI 10.1046/j.1365-2168.2001.01719.x, PubMed 11260107

Nesbakken A, Nygaard K, Lunde OC (2001)
Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer - Reply
Br. J. Surg., 88 (9), 1266-1267

Nesbakken A, Nygaard K, Lunde OC (2001)
Outcome and late functional results after anastomotic leakage following mesorectal excision for rectal cancer
In British journal of surgery, Wiley, Oxford, 88(2001)nr 3, s.400-404
BIBSYS 022001042

Publications 2000

Mala T, Lunde OC, Nesbakken A, Aadland E, Stiris M (2000)
[Endoscopic retrograde cholangiopancreatography--a 4-year retrospective study]
Tidsskr Nor Laegeforen, 120 (5), 560-2
PubMed 10833912

Mala T, Lunde OC, Nesbakken A, Aadland E, Stiris M (2000)
Endoskopisk retrograd kolangiopankreatikografi: et fireårsmateriale
In Tidsskrift for Den norske legeforening, Foreningen, Oslo, 120(2000)nr. 5, S. 560-2
BIBSYS 010704272

Nesbakken A, Nygaard K, Bull-Njaa T, Carlsen E, Eri LM (2000)
Bladder and sexual dysfunction after mesorectal excision for rectal cancer
Br J Surg, 87 (2), 206-10
DOI 10.1046/j.1365-2168.2000.01357.x, PubMed 10671929

Publications 1991

Naess F, Nesbakken A, Pillgram-Larsen J, Solheim K, Stadaas JO (1991)
[Diaphragmatic injuries]
Tidsskr Nor Laegeforen, 111 (15), 1845-6
PubMed 1853315

Publications 1990

Naess F, Nesbakken A, Pillgram-Larsen J, Gerner T, Solheim K, Stadaas JO (1990)
[Grading and prognosis of blunt abdominal injuries]
Tidsskr Nor Laegeforen, 110 (13), 1676-9
PubMed 2368048

Naess F, Nesbakken A, Solheim K, Pillgram-Larsen J, Gerner T, Stadaas JO (1990)
[Delayed surgery in blunt abdominal trauma]
Tidsskr Nor Laegeforen, 110 (7), 826-9
PubMed 2321206

Naess F, Nesbakken A, Solheim K, Pillgram-Larsen J, Gerner T, Stadaas JO (1990)
Missed diagnosis and delayed laparotomy in blunt abdominal trauma
Int J Risk Saf Med, 1 (2), 141-7
DOI 10.3233/JRS-1990-1207, PubMed 23511592

Nesbakken A, Naess F, Gerner T, Solheim K, Stadaas JO, Pillgram-Larsen J (1990)
[Diagnostic peritoneal lavage in blunt abdominal trauma]
Tidsskr Nor Laegeforen, 110 (6), 711-2
PubMed 2321193

Nesbakken A, Naess F, Solheim K, Pillgram-Larsen J, Gerner T, Stadaas JO (1990)
[Abdominal injuries after blunt trauma]
Tidsskr Nor Laegeforen, 110 (23), 2994-8
PubMed 2237848

Nesbakken A, Pillgram-Larsen J, Naess F, Gerner T, Solheim K, Stadaas JO, Gjøra O (1990)
[Penetrating abdominal injuries]
Tidsskr Nor Laegeforen, 110 (6), 705-8
PubMed 2321192

Publications 1989

Naess F, Nesbakken A, Gerner T, Stadaas JO (1989)
[Surgical treatment of pancreatic injuries]
Tidsskr Nor Laegeforen, 109 (1), 56-8
PubMed 2911817

Nesbakken A, Buanes T, Gerner T, Naess F, Stadaas JO (1989)
[Duodenal injuries due to blunt trauma]
Tidsskr Nor Laegeforen, 109 (26), 2659-61
PubMed 2814993

Nesbakken A, Haffner J (1989)
Colo-recto-anal intussusception. Case report
Acta Chir Scand, 155 (3), 201-4
PubMed 2741629

Publications 1988

Nesbakken A, Alho A, Bjersand AJ, Jensen DK, Stangeland L, Walløe A (1988)
Open tibial fractures treated with Hoffmann external fixation
Arch Orthop Trauma Surg (1978), 107 (4), 248-52
DOI 10.1007/BF00449678, PubMed 3408322

Nesbakken A, Gerner T (1988)
[Gangrene of the right colon due to hemorrhagic shock]
Tidsskr Nor Laegeforen, 108 (32), 2974
PubMed 3252545